Surgical Therapy for Macular Edema: What We Have Learned through the Decades

REFERENCES

• Coscas G, Cunha-Vaz J, Soubrane G. Macular edema: definition and basic concepts. Dev Ophthalmol. 2017;58:1–10.
   PubMedGoogle Scholar
• Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol. 2004;49:470–490.
   PubMed Web of Science ®Google Scholar
• Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007;144:741–746.
   PubMed Web of Science ®Google Scholar
• Kuiper EJ, de Smet MD, van Meurs JC, et al. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol. 2006;124:1457–1462.
   PubMed Web of Science ®Google Scholar
• Wolfensberger TJ. Macular edema - rationale for therapy. Dev Ophthalmol. 2017;58:74–86.
   PubMedGoogle Scholar
• Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–759.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116:87–93.
   PubMed Web of Science ®Google Scholar
• Praidou A, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, Dimitrakos S. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmol. 2011;89:248–254.
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Chikaraishi Y, Izuta H, et al. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology. 2008;115:1916–1922.
   PubMed Web of Science ®Google Scholar
• Bresnick GH. Diabetic macular edema: a review. Ophthalmology. 1986;93:989–997.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: IV. Diabetic macular edema. Ophthalmology. 1984;91:1464–1474.
   PubMed Web of Science ®Google Scholar
• Capitão M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117:2443–2453.
   PubMed Web of Science ®Google Scholar
• Kovacs K, Marra KV, Yu G, et al. Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia. Invest Ophthalmol Vis Sci. 2015;56:6523–6530.
   PubMed Web of Science ®Google Scholar
• Fernandez-Patron C, Zouki C, Whittal R, Chan JS, Davidge ST, Filep JG. Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]. Faseb J. 2001;15:2230–2240.
   PubMed Web of Science ®Google Scholar
• Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB. TGF-β increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci. 2001;42:853–859.
   PubMed Web of Science ®Google Scholar
• Allt G, Lawrenson JG. Pericytes: cell biology and pathology. Cells Tissues Organs. 2001;169:1–11.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Smyth N, Niessen C. Pathophysiology of diabetic macular edema. Dev Ophthalmol. 2007;39:1–12.
   PubMedGoogle Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33.
   PubMed Web of Science ®Google Scholar
• Cacciamani A, Esposito G, Scarinci F, et al. Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2019;257:187–197.
   PubMed Web of Science ®Google Scholar
• Kimura K, Orita T, Kobayashi Y, Matsuyama S, Fujimoto K, Yamauchi K. Concentration of acute phase factors in vitreous fluid in diabetic macular edema. Jpn J Ophthalmol. 2017;61:479–483.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119:789–801.
   PubMed Web of Science ®Google Scholar
• Maturi RK, Glassman AR, Liu D, et al. Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR network phase 2 randomized clinical trial. JAMA Ophthalmol. 2018;136:29–38.
   PubMed Web of Science ®Google Scholar
• Haller JA, Qin H, Apte RS, et al. Diabetic retinopathy clinical research network writing committee, vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117:1087–1093.
   PubMed Web of Science ®Google Scholar
• Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 2000;130:178–186.
   PubMed Web of Science ®Google Scholar
• Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54:1–32.
   PubMed Web of Science ®Google Scholar
• Kadonosono K, Itoh N, Ohno S. Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema. Am J Ophthalmol. 2000;130:740–744.
   PubMed Web of Science ®Google Scholar
• Park JH, Woo SJ, Ha YJ, Yu HG. Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247:1009–1017.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132:369–377.
   PubMed Web of Science ®Google Scholar
• Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol. 1997;81:919–926.
   PubMed Web of Science ®Google Scholar
• Gandorfer A. Diffuse diabetic macular edema: pathology and implications for surgery. Dev Ophthalmol. 2007;39:88–95.
   PubMedGoogle Scholar
• Hagenau F, Vogt D, Ziada J, et al. Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface. Am J Ophthalmol. 2019;200:34–46.
   Web of Science ®Google Scholar
• Shimada H, Akaza E, Yuzawa M, Kawashima M. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema. Invest Ophthalmol Vis Sci. 2009;50:2953–2955.
   PubMed Web of Science ®Google Scholar
• Lim LS, Tan L, Perera S. Retinal vessel oxygen saturation increases after vitrectomy. Invest Ophthalmol Vis Sci. 2014;55:3851–3856.
   PubMed Web of Science ®Google Scholar
• Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95:1335–1339.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 1997;104:473–478.
   PubMed Web of Science ®Google Scholar
• Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P. Pars plana vitrectomy for diabetic macular edema: a systemic review, meta-analysis, and synthesis of safety literature. Retina. 2017;37:886–895.
   PubMed Web of Science ®Google Scholar
• Simunovic MP, Hunyor AP, Ho IV. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol. 2014;49:188–195.
   PubMed Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29:464–472.
   PubMed Web of Science ®Google Scholar
• Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol. 2005;140:295–301.
   PubMed Web of Science ®Google Scholar
• Yang CM. Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina. 2000;20:121–125.
   PubMed Web of Science ®Google Scholar
• Kumagai K, Hangai M, Ogino N, Larson E. Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema. Retina. 2015;35:1422–1428.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Roggia MF, Noda Y, Ueta T. Effect of internal limiting membrane peeling during vitrectomy for diabetic macular edema: systematic review and meta-analysis. Retina. 2015;35:1719–1725.
   PubMed Web of Science ®Google Scholar
• Rinaldi M, dell’Omo R, Morescalchi F, et al. ILM peeling in nontractional diabetic macular edema: review and metanalysis. Int Ophthalmol. 2018;38:2709–2714.
   PubMed Web of Science ®Google Scholar
• Gelman R, Stevenson W, Prospero Ponce C, Agarwal D, Christoforidis JB. Retinal damage induced by internal limiting membrane removal. J Ophthalmol. 2015;2015:939748.
   PubMedGoogle Scholar
• Lee SS, Ghosn C, Yu Z, et al. Vitreous VEGF clearance is increased after vitrectomy. Invest Ophthalmol Vis Sci. 2010;51:2135–2138.
   PubMed Web of Science ®Google Scholar
• Bressler SB, Melia M, Glassman AR, et al. Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy. Retina. 2015;35:2516–2528.
   PubMed Web of Science ®Google Scholar
• Browning DJ, Lee C, Stewart MW, Landers MB 3rd. Vitrectomy for center-involved diabetic macular edema. Clin Ophthalmol. 2016;10:735–742.
   PubMed Web of Science ®Google Scholar
• Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132:1309–1316.
   PubMed Web of Science ®Google Scholar
• Sun JK, Radwan SH, Soliman AZ, et al. Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema. Diabetes. 2015;64:2560–2570.
   PubMed Web of Science ®Google Scholar
• Chhablani JK, Kim JS, Cheng L, Kozak I, Freeman W. External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2012;250:1415–1420.
   PubMed Web of Science ®Google Scholar
• Yanyali A, Bozkurt KT, Macin A, Horozoglu F, Nohutcu AF. Quantitative assessment of photoreceptor layer in eyes with resolved edema after pars plana vitrectomy with internal limiting membrane removal for diabetic macular edema. Ophthalmologica. 2011;226:57–63.
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Edwards AR, Aiello LP, et al. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina. 2010;30:1488–1495.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Suzuma K, Ryu M, Tsuiki E, Fujikawa A, Kitaoka T. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling. Curr Eye Res. 2013;38:1261–1265.
   PubMed Web of Science ®Google Scholar
• Shah SP, Patel M, Thomas D, Aldington S, Laidlaw DA. Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol. 2006;90:33–36.
   PubMed Web of Science ®Google Scholar
• Iglicki M, Lavaque A, Ozimek M, et al. Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: the VITAL Study. PLoS One. 2018;13:e0200365.
   PubMed Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332–336.
   PubMed Web of Science ®Google Scholar
• Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108:1140–1144.
   PubMed Web of Science ®Google Scholar
• Ossewaarde-van Norel A, Rothova A. Clinical review: update on treatment of inflammatory macular edema. Ocul Immunol Inflamm. 2011;19:75–83.
   PubMed Web of Science ®Google Scholar
• Waters FM, Goodall K, Jones NP, McLeod D. Vitrectomy for vitreous opacification in Fuchs’ heterochromic uveitis. Eye. 2000;14:216–218.
   PubMed Web of Science ®Google Scholar
• Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247:1019–1023.
   PubMed Web of Science ®Google Scholar
• Dugel PU, Rao NA, Ozler S, Liggett PE, Smith RE. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology. 1992;99:1535–1541.
   PubMed Web of Science ®Google Scholar
• Wiechens B, Nölle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474–481.
   PubMed Web of Science ®Google Scholar
• Stavrou P, Baltatzis S, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001;9:141–151.
   PubMed Web of Science ®Google Scholar
• Llorenç V, Keller J, Pelegrín L, Adán A. Pars plana vitrectomy for vitreo-retinal complications of birdshot chorioretinopathy. Ocul Immunol Inflamm. 2011;19:346–352.
   PubMed Web of Science ®Google Scholar
• Henry CR, Becker MD, Yang Y, Davis JL. Pars plana vitrectomy for the treatment of uveitis. Am J Ophthalmol. 2018;190:142–149.
   PubMed Web of Science ®Google Scholar
• Wiechens B, Reichelt JA, Urbat C, Nölle B. Pars plana vitrectomy in cystoid macular edema of different forms of chronic uveitis. Ophthalmologe. 2003;100:33–43.
   PubMed Web of Science ®Google Scholar
• Gutfleisch M, Spital G, Mingels A, Pauleikhoff D, Lommatzsch A, Heiligenhaus A. Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations. Br J Ophthalmol. 2007;91:345–348.
   PubMed Web of Science ®Google Scholar
• Tranos P, Scott R, Zambarakji H, Ayliffe W, Pavesio C, Charteris DG. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study. Br J Ophthalmol. 2006;90:1107–1110.
   PubMed Web of Science ®Google Scholar
• Schaal S, Tezel TH, Kaplan HJ. Surgical intervention in refractory CME–role of posterior hyaloid separation and internal limiting membrane peeling. Ocul Immunol Inflamm. 2008;16:209–210.
   PubMed Web of Science ®Google Scholar
• Cho M, D’Amico DJ. Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema. Clin Ophthalmol. 2012;6:981–989.
   PubMedGoogle Scholar
• Hikichi T, Trempe CL. Role of the vitreous in the prognosis of peripheral uveitis. Am J Ophthalmol. 1993;116:401–405.
   PubMed Web of Science ®Google Scholar
• Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1094–1101.
   PubMed Web of Science ®Google Scholar
• Panakanti TK, Chhablani J. Clinical trials in branch retinal vein occlusion. Middle East Afr J Ophthalmol. 2016;23:38–43.
   PubMed Web of Science ®Google Scholar
• Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina. 2004;24:348–355.
   PubMed Web of Science ®Google Scholar
• Hvarfner C, Larsson J. Vitrectomy for non-ischaemic macular oedema in retinal vein occlusion. Acta Ophthalmol Scand. 2006;84:812–814.
   PubMedGoogle Scholar
• DeCroos FC, Shuler RK Jr, Stinnett S, Fekrat S. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol. 2009;147:627–633.
   PubMed Web of Science ®Google Scholar
• Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina. 2010;30:117–124.
   PubMed Web of Science ®Google Scholar
• Shirakata Y, Fujita T, Nakano Y, Shiraga F, Tsujikawa A. Pars plana vitrectomy combined with internal limiting membrane peeling to treat persistent macular edema after anti-vascular endothelial growth factor treatment in cases of ischemic central retinal vein occlusion. Case Rep Ophthalmol. 2016;7:1–8.
   PubMed Web of Science ®Google Scholar
• Shirakata Y, Fukuda K, Fujita T, et al. Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments. Clin Ophthalmol. 2016;10:277–283.
   PubMed Web of Science ®Google Scholar
• Martinez MR, Ophir A. Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2011;249:811–820.
   PubMed Web of Science ®Google Scholar
• Okunuki Y, Usui Y, Katai N, et al. Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol. 2011;151:610–616.
   PubMed Web of Science ®Google Scholar
• Stefánsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31:284–289.
   PubMed Web of Science ®Google Scholar
• Sekiryu T, Yamauchi T, Enaida H, Hara Y, Furuta M. Retina tomography after vitrectomy for macular edema of central retinal vein occlusion. Ophthalmic Surg Lasers. 2000;31:198–202.
   PubMedGoogle Scholar
• Leizaola-Fernández C, Suárez-Tatá L, Quiroz-Mercado H, et al. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol. 2005;5:10.
   PubMedGoogle Scholar
• Aref AA, Scott IU. Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update. Adv Ther. 2011;28:28–39.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, Shimada K. Visual acuity and foveal thickness after vitrectomy for macular edema. Ophthalmologica. 2010;224:367–373.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K. Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series. BMC Ophthalmol. 2010;10:11.
   PubMed Web of Science ®Google Scholar
• Nishida A, Kojima H, Kameda T, Mandai M, Kurimoto Y. Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion. Clin Ophthalmol. 2017;11:369–375.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Konno S, Trempe CL. Role of the vitreous in central retinal vein occlusion. Retina. 1995;15:29–33.
   PubMed Web of Science ®Google Scholar
• Wolf S, Schnurbusch U, Wiedemann P, Grosche J, Reichenbach A, Wolburg H. Peeling of the basal membrane in the human retina: ultrastructural effects. Ophthalmology. 2004;111:238–243.
   PubMed Web of Science ®Google Scholar
• Liang XL, Chen HY, Huang YS, et al. Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study. Ann Acad Med Singapore. 2007;36:293–297.
   PubMed Web of Science ®Google Scholar
• Adelman RA, Parnes AJ, Bopp S, Saad Othman I, Ducournau D. Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study. Biomed Res Int. 2015;2015:870987.
   PubMed Web of Science ®Google Scholar
• Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2004;242:273–278.
   PubMed Web of Science ®Google Scholar
• Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599–619.
   PubMed Web of Science ®Google Scholar
• Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema. Surv Ophthalmol. 1984;28:499–504.
   PubMed Web of Science ®Google Scholar
• Schubert HD. Cystoid macular edema: the apparent role of mechanical factors. Prog Clin Biol Res. 1989;312:277–291.
   PubMedGoogle Scholar
• Pendergast SD, Margherio RR, Williams GA, Cox MS Jr. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999;128:317–323.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Canakis C, Livir-Rallatos C, Conway MD. The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: a report of two cases. Am J Ophthalmol. 2002;133:571–572.
   PubMed Web of Science ®Google Scholar
• García-Arumí J, Martinez V, Sararols L, Corcostegui B. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology. 2003;110:1164–1169.
   PubMed Web of Science ®Google Scholar